These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33528031)

  • 1. Expression of the novel tumour suppressor sterile alpha motif and HD domain-containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphoma.
    Xagoraris I; Vassilakopoulos TP; Drakos E; Angelopoulou MK; Panitsas F; Herold N; Medeiros LJ; Giakoumis X; Pangalis GA; Rassidakis GZ
    Br J Haematol; 2021 May; 193(3):488-496. PubMed ID: 33528031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens.
    Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Viviani S; Bonfante V; Nadali G; Herling M; Angelopoulou MK; Giardini R; Chilosi M; Kittas C; McDonnell TJ; Bonadonna G; Gianni AM; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    Blood; 2002 Dec; 100(12):3935-41. PubMed ID: 12433696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
    Rassidakis GZ; Medeiros LJ; Viviani S; Bonfante V; Nadali GP; Vassilakopoulos TP; Mesina O; Herling M; Angelopoulou MK; Giardini R; Chilosi M; Kittas C; McLaughlin P; Rodriguez MA; Romaguera J; Bonadonna G; Gianni AM; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    J Clin Oncol; 2002 Mar; 20(5):1278-87. PubMed ID: 11870170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
    Castillo JJ; Bower M; Brühlmann J; Novak U; Furrer H; Tanaka PY; Besson C; Montoto S; Cwynarski K; Abramson JS; Dalia S; Bibas M; Connors JM; Furman M; Nguyen ML; Cooley TP; Beltran BE; Collins JA; Vose JM; Xicoy B; Ribera JM;
    Cancer; 2015 Feb; 121(3):423-31. PubMed ID: 25251326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.
    Cottereau AS; Versari A; Loft A; Casasnovas O; Bellei M; Ricci R; Bardet S; Castagnoli A; Brice P; Raemaekers J; Deau B; Fortpied C; Raveloarivahy T; Van Zele E; Chartier L; Vander Borght T; Federico M; Hutchings M; Ricardi U; Andre M; Meignan M
    Blood; 2018 Mar; 131(13):1456-1463. PubMed ID: 29437590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative index and CD15 expression in pediatric classical Hodgkin lymphoma.
    Dinand V; Malik A; Unni R; Arya LS; Pandey RM; Dawar R
    Pediatr Blood Cancer; 2008 Feb; 50(2):280-3. PubMed ID: 17417795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma.
    Bauer K; Skoetz N; Monsef I; Engert A; Brillant C
    Cochrane Database Syst Rev; 2011 Aug; (8):CD007941. PubMed ID: 21833963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a simplified international prognostic score (IPS-3) in patients with advanced-stage classic Hodgkin lymphoma.
    Hayden AR; Lee DG; Villa D; Gerrie AS; Scott DW; Slack GW; Sehn LH; Connors JM; Savage KJ
    Br J Haematol; 2020 Apr; 189(1):122-127. PubMed ID: 31822034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy overcomes adverse prognostic role of cyclooxygenase-2 expression on Reed-Sternberg cells in early Hodgkin lymphoma.
    Mestre F; Gutiérrez A; Rodriguez J; Ramos R; Garcia JF; Martinez-Serra J; Casasus M; Nicolau C; Bento L; Herraez I; Lopez-Perezagua P; Daumal J; Besalduch J
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):84-90. PubMed ID: 25475251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong KDM4B and KDM4D Expression Associates with Radioresistance and Aggressive Phenotype in Classical Hodgkin Lymphoma.
    Bur H; Haapasaari KM; Turpeenniemi-Hujanen T; Kuittinen O; Auvinen P; Marin K; Soini Y; Karihtala P
    Anticancer Res; 2016 Sep; 36(9):4677-83. PubMed ID: 27630312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era.
    Jalali A; Ha FJ; Chong G; Grigg A; Mckendrick J; Schwarer AP; Doig R; Hamid A; Hawkes EA
    Ann Hematol; 2016 Apr; 95(5):809-16. PubMed ID: 26878861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols.
    Greaves W; Xiao L; Sanchez-Espiridion B; Kunkalla K; Dave KS; Liang CS; Singh RR; Younes A; Medeiros LJ; Vega F
    J Hematol Oncol; 2012 Aug; 5():47. PubMed ID: 22871336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of IL-6 in Hodgkin Lymphoma.
    Bhethanabhotla S; Tiwari A; Sharma MC; Vishnubhatla S; Bakhshi S
    Indian J Pediatr; 2019 Jun; 86(6):551-554. PubMed ID: 30830568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients.
    Dann EJ; Bairey O; Bar-Shalom R; Mashiach T; Barzilai E; Kornberg A; Akria L; Tadmor T; Filanovsky K; Abadi U; Kagna O; Ruchlemer R; Abdah-Bortnyak R; Goldschmidt N; Epelbaum R; Horowitz NA; Lavie D; Ben-Yehuda D; Shpilberg O; Paltiel O
    Br J Haematol; 2017 Sep; 178(5):709-718. PubMed ID: 28589704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14).
    Gillessen S; Plütschow A; Fuchs M; Markova J; Greil R; Topp MS; Meissner J; Zijlstra JM; Eichenauer DA; Bröckelmann PJ; Diehl V; Borchmann P; Engert A; von Tresckow B
    Lancet Haematol; 2021 Apr; 8(4):e278-e288. PubMed ID: 33770483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involved node radiation therapy: an effective alternative in early-stage hodgkin lymphoma.
    Maraldo MV; Aznar MC; Vogelius IR; Petersen PM; Specht L
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1057-65. PubMed ID: 23200817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy.
    Simontacchi G; Filippi AR; Ciammella P; Buglione M; Saieva C; Magrini SM; Livi L; Iotti C; Botto B; Vaggelli L; Re A; Merli F; Ricardi U
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1077-1083. PubMed ID: 26031367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation.
    Gunther JR; Fanale MA; Reddy JP; Akhtari M; Smith GL; Pinnix CC; Milgrom SA; Yehia ZA; Allen PK; Osborne EM; Mawlawi O; Dabaja BS
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):110-8. PubMed ID: 27325479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes of children with Hodgkin lymphoma between 2000 and 2010: First report by the South African Children's Cancer Study Group.
    Geel JA; Chirwa TC; Rowe B; Eyal KC; Omar F; Stones DK; Goga Y; Stefan DC; van Zyl A; Van Emmenes B; Wedi O; Vaithilingum M; Hendricks MG;
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28383768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma.
    Xicoy B; Ribera JM; Miralles P; Berenguer J; Rubio R; Mahillo B; Valencia ME; Abella E; López-Guillermo A; Sureda A; Morgades M; Navarro JT; Esteban H; ;
    Haematologica; 2007 Feb; 92(2):191-8. PubMed ID: 17296568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.